Olaf Riess

发表

UPDtool: a tool for detection of iso- and heterodisomy in parent-child trios using SNP microarrays

Marc Sturm, Christopher M. Schroeder, Thomas Eggermann, 2013, Bioinform..

A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome

Bertrand Fontaine, Carles Hernandez-Ferrer, Katja Lohmann, 2020, Orphanet Journal of Rare Diseases.

Dynamic footprints of α-synucleinopathic mice recorded by CatWalk gait analysis

Ivanna K. Timotius, Jochen Klucken, Cristian Pasluosta, 2018, Data in brief.

Expression mapping of tetracycline-responsive prion protein promoter: Digital atlasing for generating cell-specific disease models

Olaf Riess, Jana Boy, Trygve B. Leergaard, 2006, NeuroImage.

Atlas of transgenic Tet-Off Ca2+/calmodulin-dependent protein kinase II and prion protein promoter activity in the mouse brain

Trygve B. Leergaard, Jan G. Bjaalie, Olaf Riess, 2011, NeuroImage.

Raman imaging of α-synuclein aggregates in a rat model of Parkinson’s disease

Katja Schenke-Layland, Fide Sevgi, Olaf Riess, 2019, BiOS.

The risk of re-identification versus the need to identify individuals in rare disease research

Simon Woods, Domenica Taruscio, Hanns Lochmüller, 2016, European Journal of Human Genetics.

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease

Aldo Quattrone, Nobutaka Hattori, Anthony E. Lang, 2011, Neurobiology of Aging.

Transcriptional response of Escherichia coli to ammonia and glucose fluctuations

Oliver Sawodny, Ralf Takors, Ronny Feuer, 2017, Microbial biotechnology.

International Charter of principles for sharing bio-specimens and data

Simon Woods, Bartha M Knoppers, Pauline McCormack, 2014, European Journal of Human Genetics.

Transgenic rat model of Huntington's disease.

Thomas Walther, Martin Paul, Michael Bader, 2003, Human molecular genetics.

LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.

Wolfgang Wurst, Thomas Hentrich, Olaf Riess, 2013, Biochimica et biophysica acta.

Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17)

Olaf Riess, Peter Bauer, Ludger Schöls, 2003, Annals of neurology.

SCA3: Neurological features, pathogenesis and animal models

Annalisa Pastore, Olaf Riess, Peter Bauer, 2008, The Cerebellum.

Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.

Ronald Wetzel, Olaf Riess, Huu Phuc Nguyen, 2006, Human molecular genetics.

RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases

Rachel Thompson, Hanns Lochmüller, Holm Graessner, 2018, European Journal of Human Genetics.

Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease

Bernd J. Pichler, Jörg B. Schulz, Jürgen Winkler, 2008, The Journal of Neuroscience.

Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study.

Olaf Riess, Klaus Berger, Bernhard T Baune, 2008, Psychoneuroendocrinology.

Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats

Yasin Temel, Christoph Schmitz, Olaf Riess, 2006, Neurobiology of Disease.

Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12

Melvin G McInnis, Olaf Riess, Christopher A Ross, 1999, Nature Genetics.

The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysis.

Enrico Garattini, Wolfgang Engel, Olaf Riess, 2005, Molecular genetics and metabolism.

Behavioral and In Vivo Electrophysiological Evidence for Presymptomatic Alteration of Prefrontostriatal Processing in the Transgenic Rat Model for Huntington Disease

Olaf Riess, Huu Phuc Nguyen, Sophie Höhn, 2011, The Journal of Neuroscience.

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Oliver Kohlbacher, Sven Nahnsen, Mathias Walzer, 2016, Journal of hepatology.

Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease

Stephen C. Fowler, George V. Rebec, Olaf Riess, 2010, Neurobiology of Disease.

Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease

Olaf Riess, K. Andres, R. Dermietzel, 2007 .

Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.

Olaf Riess, K. Andres, R. Dermietzel, 2007, The Journal of comparative neurology.

A rapid microarray based whole genome analysis for detection of uniparental disomy

Murat Bastepe, Thomas Eggermann, Andreas Dufke, 2005, Human mutation.

Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing

Jean-François Dartigues, Günther Deuschl, Yoav Ben-Shlomo, 2017, Genome Biology.

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

Kay Nieselt, Tanja Fehm, Olaf Riess, 2006, Cancer research.

Neurobehavioral tests in rat models of degenerative brain diseases.

Olaf Riess, Huu Phuc Nguyen, Stephan von Hörsten, 2010, Methods in molecular biology.

Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3.

Hartwig Wolburg, Ina Schmitt, Thorsten Schmidt, 2009, Human molecular genetics.

Association between genetic variants of IL-1β, IL-6 and TNF-α cytokines and cognitive performance in the elderly general population of the MEMO-study

Bernhard T. Baune, Olaf Riess, Klaus Berger, 2008, Psychoneuroendocrinology.

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis

Thorsten Schmidt, Olaf Riess, Peter Bauer, 2004, The Lancet Neurology.

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Olaf Riess, Ludger Schols, R. Krüger, 1998, Nature Genetics.

Automated behavioral phenotyping reveals presymptomatic alterations in a SCA3 genetrap mouse model.

Olaf Riess, Huu Phuc Nguyen, Stephan von Hörsten, 2012, Journal of genetics and genomics = Yi chuan xue bao.

Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.

Andreas Bauer, Olaf Riess, Michael Bonin, 2008, Human molecular genetics.

Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation

Andreas Bauer, Olaf Riess, Andreas Matusch, 2005, Journal of neurochemistry.

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Aldo Quattrone, Nobutaka Hattori, Mariza de Andrade, 2006, JAMA.

Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: A multicenter study

Luminita Moruz, Andreas Dufke, Olaf Riess, 2009, Human mutation.

14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.

Daniela Berg, Olaf Riess, Klaus Berger, 2002, Brain research. Molecular brain research.

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Johannes Kornhuber, Zacharias Kohl, Bernd J Pichler, 2013, Brain : a journal of neurology.